CA2237956A1 - 2'-[[4'-halo-[1,1'-biphenyl]-4-yl]methyl]-5'-methyl-spiro[cyclopentane-1,7'(8'h)-[3h]imidazo[2,1-b]purin]-4'(5'h)-ones - Google Patents
2'-[[4'-halo-[1,1'-biphenyl]-4-yl]methyl]-5'-methyl-spiro[cyclopentane-1,7'(8'h)-[3h]imidazo[2,1-b]purin]-4'(5'h)-ones Download PDFInfo
- Publication number
- CA2237956A1 CA2237956A1 CA002237956A CA2237956A CA2237956A1 CA 2237956 A1 CA2237956 A1 CA 2237956A1 CA 002237956 A CA002237956 A CA 002237956A CA 2237956 A CA2237956 A CA 2237956A CA 2237956 A1 CA2237956 A1 CA 2237956A1
- Authority
- CA
- Canada
- Prior art keywords
- methyl
- compound
- imidazo
- spiro
- purin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/20—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56371795A | 1995-11-28 | 1995-11-28 | |
US08/563,717 | 1995-11-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2237956A1 true CA2237956A1 (en) | 1997-06-05 |
Family
ID=24251614
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002237956A Abandoned CA2237956A1 (en) | 1995-11-28 | 1996-11-26 | 2'-[[4'-halo-[1,1'-biphenyl]-4-yl]methyl]-5'-methyl-spiro[cyclopentane-1,7'(8'h)-[3h]imidazo[2,1-b]purin]-4'(5'h)-ones |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0863902A1 (es) |
JP (1) | JP2000501095A (es) |
AR (1) | AR004752A1 (es) |
AU (1) | AU1055597A (es) |
CA (1) | CA2237956A1 (es) |
CO (1) | CO4480029A1 (es) |
WO (1) | WO1997019947A1 (es) |
ZA (1) | ZA969888B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6326379B1 (en) | 1998-09-16 | 2001-12-04 | Bristol-Myers Squibb Co. | Fused pyridine inhibitors of cGMP phosphodiesterase |
DE50008549D1 (de) | 1999-12-24 | 2004-12-09 | Bayer Healthcare Ag | Triazolotriazinone und ihre verwendung |
EP1252165A1 (de) | 1999-12-24 | 2002-10-30 | Bayer Aktiengesellschaft | Isoxazolopyrimidinone und ihre verwendung |
US6803365B2 (en) | 1999-12-24 | 2004-10-12 | Bayer Aktlengesellschaft | Imidazo[1,3,5]triazinones and the use thereof |
CN110337437B (zh) | 2016-12-28 | 2023-02-03 | 达特神经科学有限公司 | 作为pde2抑制剂的取代的吡唑并嘧啶酮化合物 |
EP3717488B1 (en) | 2017-11-27 | 2021-09-29 | Dart NeuroScience, LLC | Substituted furanopyrimidine compounds as pde1 inhibitors |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL98559A0 (en) * | 1990-06-21 | 1992-07-15 | Schering Corp | Polycyclic guanine derivatives |
WO1994019351A1 (en) * | 1993-02-26 | 1994-09-01 | Schering Corporation | 2-benzyl-polycyclic guanine derivatives and process for preparing them |
-
1996
- 1996-11-25 AR ARP960105319A patent/AR004752A1/es unknown
- 1996-11-25 ZA ZA969888A patent/ZA969888B/xx unknown
- 1996-11-26 CO CO96062218A patent/CO4480029A1/es unknown
- 1996-11-26 AU AU10555/97A patent/AU1055597A/en not_active Abandoned
- 1996-11-26 CA CA002237956A patent/CA2237956A1/en not_active Abandoned
- 1996-11-26 WO PCT/US1996/018550 patent/WO1997019947A1/en not_active Application Discontinuation
- 1996-11-26 EP EP96941401A patent/EP0863902A1/en not_active Withdrawn
- 1996-11-26 JP JP9520543A patent/JP2000501095A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
MX9804198A (es) | 1998-10-31 |
WO1997019947A1 (en) | 1997-06-05 |
AU1055597A (en) | 1997-06-19 |
EP0863902A1 (en) | 1998-09-16 |
AR004752A1 (es) | 1999-03-10 |
JP2000501095A (ja) | 2000-02-02 |
ZA969888B (en) | 1997-05-26 |
CO4480029A1 (es) | 1997-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5824683A (en) | 2'- 4'-halo- 1,1'-biphenyl!-4-yl!methyl!-5'-methyl-spiro cyclopentane-1,7' (8'H)- 3H! imidazo 2,1-b!purin!-4' (5'H)-ones | |
AU708750B2 (en) | 6-substituted pyrazolo {3,4-d} pyrimidin-4-ones and compositions and methods of use thereof | |
CA2408596C (en) | New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound | |
EP1165558B1 (en) | Derivatives of pyrimido[6,1-a]isoquinolin-4-one | |
US20030069260A1 (en) | 1-alkyl or 1-cycloalkyltriazolo[4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors | |
JPH11502859A (ja) | ピラゾール誘導体およびその製造法 | |
DE102006029447A1 (de) | Oxo-substituierte Imidazo[1,2b]pyridazine, deren Herstellung und Verwendung als Arzneimittel | |
DE60001735T2 (de) | 1-aminotriazolo 4,3-a chinazolin-5-one und/oder -thione inhibitoren von phosphodiesterasen iv | |
AU708809B2 (en) | 6-aryl pyrazolo{3,4-d}pyrimidin-4-ones and compositions and methods of use thereof | |
CA2119579A1 (en) | Heterocyclic compounds and their preparation and use | |
CA2237956A1 (en) | 2'-[[4'-halo-[1,1'-biphenyl]-4-yl]methyl]-5'-methyl-spiro[cyclopentane-1,7'(8'h)-[3h]imidazo[2,1-b]purin]-4'(5'h)-ones | |
JPS62169783A (ja) | イミダゾ〔1,2−a〕キノリン誘導体、その製造法およびその医薬への応用 | |
CN110627795A (zh) | 磷酸二酯酶抑制剂及其用途 | |
CN117865965B (zh) | 吡咯并嘧啶-4-胺和吡唑并嘧啶-4-胺衍生物及制备方法和应用 | |
MXPA97006878A (es) | Pirazolo [3,4-d]pirimidin-4-onas 6-arilo y composiciones y metodos para su uso | |
MXPA97006876A (es) | Pirazolo[3,4-d]pirimidin-4-onas 6-sustituidas y composiciones y metodo para su uso |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |